Discover 3,086 paid clinical trials in Worcester, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,086
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Worcester MA, Burlington MA, Springfield MA, Peabody MA,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06616584
Phase 2, Phase 3, Recruiting
A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting
for
Pneumonia
Location: Worcester MA, Baltimore MD, Washington D.C. DC,
Sponsor: Pfizer
Sex: All
Age: 65+
Code: NCT05452941
Recruiting
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
for
Intracerebral Hemorrhage, Atrial Fibrillation
Location: Worcester MA, Burlington MA, Boston MA, Springfield MA,
Sponsor: Yale University
Sex: All
Age: 18+
Code: NCT03907046
Phase 3, Recruiting
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
for
Childhood Extracranial Germ Cell Tumor,
Location: Worcester MA, Boston MA, Providence RI, Springfield MA,
Sponsor: Children's Oncology Group
Sex: All
Age: 0+
Code: NCT03067181
Phase 3, Recruiting
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Project: Every Child for Younger Patients With Cancer
for
Adrenal Gland Pheochromocytoma, Carcinoma In Situ,
Location: Worcester MA, Boston MA, Providence RI, Springfield MA,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 25
Code: NCT02402244
Recruiting
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
for
Immunoglobulin A Nephropathy (IgAN)
Location: Worcester MA, Boston MA, Providence RI, The Bronx NY,
Sponsor: Biogen
Sex: All
Age: 18+
Code: NCT06935357
Phase 3, Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
for
Acute Myeloid Leukemia
Location: Worcester MA, Boston MA, Providence RI, Hartford CT,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT04293562
Phase 3, Recruiting
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Location: Worcester MA, Hartford CT, Waterford CT, New Britain CT,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT04181060
Phase 3, Recruiting
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
for
Lung Non-Small Cell Carcinoma
Location: Worcester MA, Burlington MA, Springfield MA, Peabody MA,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06116682
Phase 2, Recruiting
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
for
Acute Leukemia of Ambiguous Lineage,
Location: Worcester MA, Boston MA, Providence RI, Hartford CT,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 1
Code: NCT06317662
Phase 2, Recruiting
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
for
Carcinoma, Non-Small-Cell Lung
Location: Worcester MA, Hartford CT, Westbrook ME, New York NY,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06890598
Phase 3, Recruiting
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
for
Non-Small Cell Lung Cancer (NSCLC)
Location: Worcester MA, Montreal, Sayre PA, Media PA, Newark DE,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT05920356
Phase 3, Recruiting
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
for
Non-Small Cell Lung Cancer
Location: Worcester MA, Foxborough MA, Brighton MA, Boston MA,
Sponsor: Summit Therapeutics
Sex: All
Age: 18+
Code: NCT06767514
Phase 3, Recruiting
New
Supporting Treatment Access and Recovery in Re-entry (STAR-R)